Peptide-retargeted adenovirus encoding a tissue inhibitor of metalloproteinase-1 decreases restenosis after intravascular gene transfer

Molecular Therapy

Volumn 6, Issue 3, 2002, Pages 306-312

  Turunen, Mikko P ^a   Puhakka, Hanna L ^a   Koponen, Jonna K ^a   Hiltunen, Mikko O ^a   Rutanen, Juha ^a   Leppänen, Olli ^a   Turunen, Anna Mari ^a   Närvänen, Ale ^a   Newby, Andrew C ^c   Baker, Andrew H ^d   Ylä Herttuala, Seppo ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Adenovirus; Gene therapy; Intravascular; Metalloproteinase; Restenosis; Targeting

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; CYCLOPEPTIDE; GELATINASE A; GELATINASE B; POLYLYSINE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA BALLOON; ARTERY INTIMA PROLIFERATION; ARTERY WALL; ARTICLE; CELL STRAIN HEPG2; CONTROLLED STUDY; DRUG DISTRIBUTION; ENDOTHELIUM CELL; ENZYME MECHANISM; GENE EXPRESSION; GENE TARGETING; GENE TRANSFER; GENETIC TRANSDUCTION; HYBRIDOMA CELL CULTURE; IN VITRO STUDY; IN VIVO STUDY; LIVER; NONHUMAN; REPORTER GENE; RESTENOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; TISSUE GROWTH; TRANSGENE; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0036765049     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1006/mthe.2002.0668     Document Type: Article

References (33)

1. Califf, R. M. (1995). Restenosis: the cost to society. Am. Heart J. 130: 680-684.
2. Manhapra, A., and Borzak, S. (2000). Treatment possibilities for unstable angina. BMJ 321: 1269-1275.
3. Rutanen, J., Rissanen, T. T., Kivela, A., Vajanto, I., and Yla-Herttuala, S. (2001). Clinical applications of vascular gene therapy. Curr. Cardiol. Rep. 3: 29-36.
4. Bittl, J. A. (1996). Advances in coronary angioplasty. N. Engl. J. Med. 335: 1290-1302.
5. Serruys, P. W., et al. (1988). Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months. Circulation 77: 361-371.
6. Wilensky, R. L., et al. (1995). Vascular injury, repair, and restenosis after percutaneous transluminal angioplasty in the atherosclerotic rabbit. Circulation 92: 2995-3005.
7. Yutani, C., et al. (1999). Coronary atherosclerosis and interventions: pathological sequences and restenosis. Pathol. Int. 49: 273-290.
8. Assoian, R. K., and Marcantonio, E. E. (1996). The extracellular matrix as a cell cycle control element in atherosclerosis and restenosis. J. Clin. Invest. 98: 2436-2439.
9. Baker, A. H., Zaltsman, A. B., George, S. J., and Newby, A. C. (1998). Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis. J. Clin. Invest. 101: 1478-1487.
10. Dollery, C. M., McEwan, J. R., and Henney, A. M. (1995). Matrix metalloproteinases and cardiovascular disease. Circ. Res. 77: 863-868.
11. Yla-Herttuala, S., and Martin, J. F. (2000). Cardiovascular gene therapy. Lancet 355: 213-222.
12. Laitinen, M., et al. (1998). Adenovirus-mediated gene transfer to lower limb artery of patients with chronic critical leg ischemia. Hum. Gene Ther. 9: 1481-1486.
13. Hiltunen, M. O., et al. (2000). Biodistribution of adenoviral vector to nontarget tissues after local in vivo gene transfer to arterial wall using intravascular and periadventitial gene delivery methods. FASEB J. 14: 2230-2236.
14. George, S. J. (1998). Tissue inhibitors of metalloproteinases and metalloproteinases in atherosclerosis. Curr. Opin. Lipidol. 9: 413-423.
15. Greene, J., et al. (1996). Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J. Biol. Chem. 271: 30375-30380.
16. Galis, Z. S., Sukhova, G. K., Lark, M. W., and Libby, P. (1994). Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J. Clin. Invest. 94: 2493-2503.
17. Nikkari, S. T., et al. (1995). Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis. Circulation 92: 1393-1398.
18. Murphy, G., Docherty, A. J., Hembry, R. M., and Reynolds, J. J. (1991). Metalloproteinases and tissue damage. Br. J. Rheumatol. 30(Suppl. 1): 25-31.
19. Koivunen, E., et al. (1999). Tumor targeting with a selective gelatinase inhibitor. Nat. Biotechnol. 17: 768-774.
20. Wagner, E., et al. (1992). Coupling of adenovirus to transferrin-polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes. Proc. Natl. Acad. Sci. USA 89: 6099-6103.
21. Librach, C. L., et al. (1991). 92-kD type IV collagenase mediates invasion of human cytotrophoblasts. J. Cell Biol. 113: 437-449.
22. George, S. J., Johnson, J. L., Angelini, A. D., Newby, A. C., and Baker, A. H. (1998). Adenovirus-mediated gene transfer of the human TIMP-1 gene inhibits smooth muscle cell migration and neointimal formation in human saphenous vein. Hum. Gene Ther. 9: 867-877.
23. Forough, R., et al. (1996). Overexpression of tissue inhibitor of matrix metalloproteinase-1 inhibits vascular smooth muscle cell functions in vitro and in vivo. Circ. Res. 79: 812-820.
24. Dollery, C. M., Humphries, S. E., McClelland, A., Latchman, D. S., and McEwan, J. R. (1999). Expression of tissue inhibitor of matrix metalloproteinases 1 by use of an adenoviral vector inhibits smooth muscle cell migration and reduces neointimal hyperplasia in the rat model of vascular balloon injury. Circulation 24: 3199-3205.
25. Biermann, V., et al. (2001). Targeting of high-capacity adenoviral vectors. Hum. Gene Ther. 12: 1757-1769.
26. Fechner, H., et al. (1999). Expression of Coxsacie adenovirus receptor and αv-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriers. Gene Ther. 6: 1520-1535.
27. Hidaka, C., et al. (1999). CAR-dependent and CAR-independent pathways of adenovirus vector-mediated gene transfer and expression in human fibroblasts. J. Clin. Invest. 103: 579-587.
28. Printz, M. A., et al, (2000). Fibroblast growth factor 2-retargeted adenoviral vectors exhibit a modified biolocalization pattern and display reduced toxicity relative to native adenoviral vectors. Hum. Gene Ther. 11: 191-204.
29. 3. Cell 85: 683-693.
30. Puumalainen, A. M., et al. (1998). β-Galactosidase gene transfer to human malignant glioma in vivo using replication-deficient retroviruses and adenoviruses. Hum. Gene Ther. 9: 1769-1774.
31. Turunen, M. P., et al. (1999). Efficient adventitial gene delivery to rabbit carotid artery with cationic polymer-plasmid complexes. Gene Ther. 6: 6-11.
32. Heurkens, A. H., et al. (1991). Methods for the detection of anti-endothelial antibodies by enzyme-linked immunosorbent assay. J. Immunol. Methods 141: 33-39.
33. Hiltunen, M. O., et al. (2000). Intravascular adenovirus-mediated VEGF-C gene transfer reduces neointima formation in balloon-denuded rabbit aorta. Circulation 102: 2262-2268.